Ardius

Caroline: Could you talk a little bit about how that clinical and biological hetergeneity mentioned impacts researching ardius and coming up with treatment? annette: We don't really have a therapeutic option other than nea on protective ventilation. And i think what we're realizing is that, because this cindrome is so heterogeneous, that might explain why years of different randamise control travels have come up with nothing new for us to treat these patients with.